0001892322 false --12-31 Q1 2022 0001892322 2022-01-01 2022-03-31 0001892322 2022-05-16 0001892322 2022-03-31 0001892322 2021-12-31 0001892322 2021-01-01 2021-03-31 0001892322 us-gaap:CommonStockMember 2020-12-31 0001892322 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001892322 us-gaap:RetainedEarningsMember 2020-12-31 0001892322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001892322 us-gaap:ParentMember 2020-12-31 0001892322 us-gaap:NoncontrollingInterestMember 2020-12-31 0001892322 2020-12-31 0001892322 us-gaap:CommonStockMember 2021-12-31 0001892322 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001892322 us-gaap:RetainedEarningsMember 2021-12-31 0001892322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001892322 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001892322 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001892322 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001892322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001892322 us-gaap:ParentMember 2021-01-01 2021-03-31 0001892322 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001892322 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001892322 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001892322 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001892322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001892322 us-gaap:CommonStockMember 2021-03-31 0001892322 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001892322 us-gaap:RetainedEarningsMember 2021-03-31 0001892322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001892322 us-gaap:ParentMember 2021-03-31 0001892322 us-gaap:NoncontrollingInterestMember 2021-03-31 0001892322 2021-03-31 0001892322 us-gaap:CommonStockMember 2022-03-31 0001892322 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001892322 us-gaap:RetainedEarningsMember 2022-03-31 0001892322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001892322 HTCR:ShareExchangeAgreementMember HTCR:StockholderMember us-gaap:CommonStockMember 2021-07-14 2021-07-16 0001892322 HTCR:ShareExchangeAgreementMember HTCR:StockholderMember us-gaap:CommonStockMember 2021-07-14 2021-07-15 0001892322 HTCR:ShareExchangeAgreementMember HTCR:StockholderMember us-gaap:CommonStockMember 2021-07-16 0001892322 2022-02-22 2022-02-24 0001892322 2021-01-01 2021-12-31 0001892322 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember HTCR:CustomerAMember 2022-01-01 2022-03-31 0001892322 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember HTCR:CustomerBMember 2021-01-01 2021-03-31 0001892322 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember HTCR:CustomerCMember 2021-01-01 2021-03-31 0001892322 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember HTCR:VendorAMember 2022-01-01 2022-03-31 0001892322 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember HTCR:VendorBMember 2022-01-01 2022-03-31 0001892322 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember HTCR:VendorCMember 2022-01-01 2022-03-31 0001892322 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember HTCR:VendorAMember 2021-01-01 2021-03-31 0001892322 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember HTCR:VendorBMember 2021-01-01 2021-03-31 0001892322 HTCR:CurrentJPYUS1ExchangeRateMember 2022-03-31 0001892322 HTCR:CurrentJPYUS1ExchangeRateMember 2021-03-31 0001892322 HTCR:AverageJPYUS1ExchangeRateMember 2022-03-31 0001892322 HTCR:AverageJPYUS1ExchangeRateMember 2021-03-31 0001892322 HTCR:OnPremiseSoftwareMember 2022-01-01 2022-03-31 0001892322 HTCR:OnPremiseSoftwareMember 2021-01-01 2021-03-31 0001892322 HTCR:MaintenanceAndSupportServiceMember 2022-01-01 2022-03-31 0001892322 HTCR:MaintenanceAndSupportServiceMember 2021-01-01 2021-03-31 0001892322 HTCR:SoftwareAsAServiceSaaSMember 2022-01-01 2022-03-31 0001892322 HTCR:SoftwareAsAServiceSaaSMember 2021-01-01 2021-03-31 0001892322 HTCR:SoftwareDevelopmentAndOtherMiscellaneousServicesMember 2022-01-01 2022-03-31 0001892322 HTCR:SoftwareDevelopmentAndOtherMiscellaneousServicesMember 2021-01-01 2021-03-31 0001892322 HTCR:CustomerExperienceManagementPlatformMember 2022-01-01 2022-03-31 0001892322 HTCR:CustomerExperienceManagementPlatformMember 2021-01-01 2021-03-31 0001892322 HTCR:ProcessMiningMember 2022-01-01 2022-03-31 0001892322 HTCR:ProcessMiningMember 2021-01-01 2021-03-31 0001892322 HTCR:RoboticProcessAutomationMember 2022-01-01 2022-03-31 0001892322 HTCR:RoboticProcessAutomationMember 2021-01-01 2021-03-31 0001892322 HTCR:TaskMiningMember 2022-01-01 2022-03-31 0001892322 HTCR:TaskMiningMember 2021-01-01 2021-03-31 0001892322 HTCR:OthersMember 2022-01-01 2022-03-31 0001892322 HTCR:OthersMember 2021-01-01 2021-03-31 0001892322 srt:ChiefExecutiveOfficerMember 2022-03-31 0001892322 srt:ChiefExecutiveOfficerMember 2021-12-31 0001892322 srt:ChiefExecutiveOfficerMember 2021-03-31 0001892322 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-03-31 0001892322 srt:ChiefExecutiveOfficerMember 2021-01-01 2021-03-31 0001892322 HTCR:HeartcoreTechnologyIncMember 2022-03-31 0001892322 HTCR:HeartcoreTechnologyIncMember 2021-12-31 0001892322 HTCR:HeartcoreTechnologyIncMember 2021-03-31 0001892322 HTCR:HeartcoreTechnologyIncMember 2022-01-01 2022-03-31 0001892322 HTCR:HeartcoreTechnologyIncMember 2021-01-01 2021-03-31 0001892322 HTCR:SuzuyoShinwartMember 2020-06-30 0001892322 HTCR:SuzuyoShinwartMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-01-01 2021-03-31 0001892322 HTCR:SuzuyoShinwartMember 2021-03-31 0001892322 us-gaap:PrivatePlacementMember us-gaap:CommonStockMember 2022-01-13 0001892322 us-gaap:PrivatePlacementMember us-gaap:CommonStockMember 2022-01-02 2022-01-13 0001892322 us-gaap:LeaseholdImprovementsMember 2022-03-31 0001892322 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001892322 us-gaap:MachineryAndEquipmentMember 2022-03-31 0001892322 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001892322 us-gaap:VehiclesMember 2022-03-31 0001892322 us-gaap:VehiclesMember 2021-12-31 0001892322 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-03-31 0001892322 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-12-31 0001892322 us-gaap:PropertyPlantAndEquipmentMember 2022-03-31 0001892322 us-gaap:PropertyPlantAndEquipmentMember 2021-12-31 0001892322 us-gaap:CorporateBondSecuritiesMember HTCR:ResonaBankLimitedMember 2022-01-01 2022-03-31 0001892322 us-gaap:CorporateBondSecuritiesMember HTCR:ResonaBankLimitedMember 2022-03-31 0001892322 us-gaap:CorporateBondSecuritiesMember HTCR:ResonaBankLimitedMember 2021-12-31 0001892322 HTCR:ResonaBankLimitedMember 2022-01-01 2022-03-31 0001892322 HTCR:ResonaBankLimitedMember 2022-03-31 0001892322 HTCR:ResonaBankLimitedMember 2021-12-31 0001892322 HTCR:ResonaBankLimitedOneMember 2022-01-01 2022-03-31 0001892322 HTCR:ResonaBankLimitedOneMember 2022-03-31 0001892322 HTCR:ResonaBankLimitedOneMember 2021-12-31 0001892322 HTCR:ResonaBankLimitedTwoMember 2022-01-01 2022-03-31 0001892322 HTCR:ResonaBankLimitedTwoMember 2022-03-31 0001892322 HTCR:ResonaBankLimitedTwoMember 2021-12-31 0001892322 HTCR:ResonaBankLimitedThreeMember 2022-01-01 2022-03-31 0001892322 HTCR:ResonaBankLimitedThreeMember 2022-03-31 0001892322 HTCR:ResonaBankLimitedThreeMember 2021-12-31 0001892322 HTCR:ResonaBankLimitedFourMember 2022-01-01 2022-03-31 0001892322 HTCR:ResonaBankLimitedFourMember 2022-03-31 0001892322 HTCR:ResonaBankLimitedFourMember 2021-12-31 0001892322 HTCR:SumitomoMitsuiBankingCorporationMember 2022-01-01 2022-03-31 0001892322 HTCR:SumitomoMitsuiBankingCorporationMember 2022-03-31 0001892322 HTCR:SumitomoMitsuiBankingCorporationMember 2021-12-31 0001892322 HTCR:SumitomoMitsuiBankingCorporationOneMember 2022-01-01 2022-03-31 0001892322 HTCR:SumitomoMitsuiBankingCorporationOneMember 2022-03-31 0001892322 HTCR:SumitomoMitsuiBankingCorporationOneMember 2021-12-31 0001892322 HTCR:TheShokoChukinBankLtdMember 2022-01-01 2022-03-31 0001892322 HTCR:TheShokoChukinBankLtdMember 2022-03-31 0001892322 HTCR:TheShokoChukinBankLtdMember 2021-12-31 0001892322 HTCR:TheShokoChukinBankLtdOneMember 2022-01-01 2022-03-31 0001892322 HTCR:TheShokoChukinBankLtdOneMember 2022-03-31 0001892322 HTCR:TheShokoChukinBankLtdOneMember 2021-12-31 0001892322 HTCR:JapanFinanceCorporationMember 2022-01-01 2022-03-31 0001892322 HTCR:JapanFinanceCorporationMember 2022-03-31 0001892322 HTCR:JapanFinanceCorporationMember 2021-12-31 0001892322 HTCR:JapanFinanceCorporationOneMember 2022-01-01 2022-03-31 0001892322 HTCR:JapanFinanceCorporationOneMember 2022-03-31 0001892322 HTCR:JapanFinanceCorporationOneMember 2021-12-31 0001892322 HTCR:HigashiNipponBankMember 2022-01-01 2022-03-31 0001892322 HTCR:HigashiNipponBankMember 2022-03-31 0001892322 HTCR:InsurancePremiumFinancingAgreementMember HTCR:BankDirectCapitalFinanceToBorrowMember 2022-02-28 0001892322 us-gaap:DomesticCountryMember 2022-01-01 2022-03-31 0001892322 us-gaap:ForeignCountryMember 2022-01-01 2022-03-31 0001892322 us-gaap:ForeignCountryMember 2021-01-01 2021-03-31 0001892322 HTCR:EmployeeMember HTCR:HeartCoreCoLtdMember 2016-05-01 2016-05-31 0001892322 HTCR:EmployeeMember HTCR:HeartCoreCoLtdMember 2016-05-31 0001892322 HTCR:HeartCoreCoLtdMember 2021-01-01 2021-03-31 0001892322 HTCR:HeartCoreCoLtdMember 2021-11-02 2021-11-03 0001892322 HTCR:HeartCoreCoLtdMember us-gaap:CommonStockMember 2021-11-02 2021-11-03 0001892322 HTCR:HeartCoreCoLtdMember 2021-12-31 0001892322 us-gaap:IPOMember 2022-02-12 2022-02-14 0001892322 2022-02-12 2022-02-14 0001892322 us-gaap:StockOptionMember 2022-01-01 2022-03-31 0001892322 us-gaap:StockOptionMember 2021-01-01 2021-03-31 0001892322 HTCR:ExecutiveEmploymentAgreementsMember HTCR:FiveExecutivesMember HTCR:TwoThousandTwentyOneEquityIncentivePlanMember 2022-02-08 2022-02-09 0001892322 HTCR:ServiceAgreementMember HTCR:ThirdPartyMember 2022-02-20 2022-02-25 0001892322 HTCR:ServiceAgreementMember HTCR:ThirdPartyMember us-gaap:SubsequentEventMember 2022-05-14 2022-05-15 0001892322 us-gaap:StockOptionMember 2020-12-31 0001892322 us-gaap:StockOptionMember 2021-03-31 0001892322 us-gaap:StockOptionMember 2021-12-31 0001892322 us-gaap:StockOptionMember 2022-03-31 0001892322 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001892322 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001892322 us-gaap:RestrictedStockUnitsRSUMember 2022-03-31 0001892322 2022-01-02 2022-01-13 0001892322 2022-01-13 0001892322 srt:OfficerMember 2022-01-02 2022-01-13 0001892322 us-gaap:IPOMember 2022-02-14 0001892322 2022-02-14 0001892322 2021-12-30 2021-12-31 0001892322 HTCR:DentsuDigitalInvestmentLimitedMember HTCR:StockPurchaseAgreementMember 2021-08-09 2021-08-10 0001892322 HTCR:DentsuDigitalInvestmentLimitedMember HTCR:StockPurchaseAgreementMember 2022-03-31 0001892322 HTCR:DentsuDigitalInvestmentLimitedMember HTCR:StockPurchaseAgreementMember 2022-02-22 2022-02-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:JPY iso4217:JPY xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2022

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______, 20___, to _____, 20___.

 

Commission File Number 001-41272

 

HeartCore Enterprises, Inc.

 

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   87-0913420

(State or Other Jurisdiction of
Incorporation or Organization)

 

(I.R.S. Employer

Identification Number)

 

1-2-33, Higashigotanda, Shinagawa-ku

Tokyo, Japan

 

(Address of Principal Executive Offices) (Zip Code)    

 

(206) 385-0488, ext. 100

(Registrant’s Telephone Number, Including Area Code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each Exchange on which Registered
Common Stock   HTCR   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of May 16, 2022, there were 18,999,276 shares of common stock, par value $0.0001 per share, of the registrant issued and outstanding.

 

 

 

 

 

 

HeartCore Enterprises, Inc.

 

Contents 

 

PART I – FINANCIAL INFORMATION  
     
Item 1. Financial Statements 2
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 18
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 29
     
Item 4. Controls and Procedures 29
     
PART II – OTHER INFORMATION  
     
Item 1. Legal Proceedings 29
     
Item 1A. Risk Factors 30
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30
     
Item 3. Defaults Upon Senior Securities 30
     
Item 4. Mine Safety Disclosures 30
     
Item 5. Other Information 30
     
Item 6. Exhibits 30
     
Signatures 32

 

1

 

 

Item 1. Financial Statements.

 

HEARTCORE ENTERPRISES, INC.

CONSOLIDATED BALANCE SHEETS

 

           
   March 31,   December 31, 
   2022   2021 
   (unaudited)     
ASSETS          
Current assets:          
Cash and cash equivalents  $13,913,886   $3,136,839 
Accounts receivable, net   1,116,254    960,964 
Prepaid expenses   1,123,050    444,405 
Due from related party   52,105    50,559 
Loan receivable from employee   7,880    8,341 
Other current assets   50,135    15,654 
Total current assets   16,263,310    4,616,762 
           
Non-current assets:          
Property and equipment, net   238,787    261,414 
Operating lease right-of-use assets   3,063,672    3,319,749 
Deferred tax assets   275,490    297,990 
Security deposits   262,851    278,237 
Long-term loan receivable from related party   304,163    335,756 
Loan receivable from employee, non-current   2,298    4,518 
Other non-current assets   6,368    8,737 
Total non-current assets   4,153,629    4,506,401 
           
Total assets  $20,416,939   $9,123,163 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)          
           
Current liabilities:          
Accounts payable and accrued expenses  $485,138   $646,425 
Accrued payroll and other employee costs   239,710    255,082 
Due to related party   185    1,110 
Current portion of long-term debts   847,316    849,995 
Insurance premium financing   347,258    - 
Operating lease liabilities, current   313,737    332,277 
Finance lease liabilities, current   29,272    37,459 
Income tax payables   739    10,919 
Deferred revenue   1,315,780    1,690,917 
Mandatorily redeemable financial interest   -    447,986 
Other current liabilities   157,725    281,673 
Total current liabilities   3,736,860    4,553,843 
           
Non-current liabilities:          
Long-term debts   1,676,848    1,871,580 
Operating lease liabilities, non-current   2,831,624    3,076,204 
Finance lease liabilities, non-current   14,425    23,861 
Other non-current liabilities   148,073    156,627 
Total non-current liabilities   4,670,970    5,128,272 
           
Total liabilities:   8,407,830    9,682,115 
           
Shareholders’ equity (deficit):          
Preferred shares ($0.0001 par value, 20,000,000 shares authorized, no shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively)   -    - 
Common shares ($0.0001 par value, 200,000,000 shares authorized; 18,915,943 and 15,819,943 shares issued; 18,915,943 and 15,546,454 shares outstanding as of March 31, 2022 and December 31, 2021, respectively)   1,891    1,554 
Additional paid-in capital   17,416,901    3,350,779 
Accumulated deficit   (5,474,564)   (3,896,113)
Accumulated other comprehensive income (loss)   64,881    (15,172)
Total shareholders’ equity (deficit)   12,009,109    (558,952)
           
Total liabilities and shareholders’ equity (deficit)  $20,416,939   $9,123,163 

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

2

 

 

HEARTCORE ENTERPRISES, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

 

     2022     2021 
  

For the Three Months Ended

March 31,

 
   2022   2021 
         
Revenues  $2,276,001   $2,110,309 
           
Cost of revenues   1,055,356    1,407,632 
           
Gross profit   1,220,645    702,677 
           
Operating expenses:          
Selling expenses   205,918    46,341 
General and administrative expenses   2,468,933    762,748 
Research and development expenses   108,259    52,146 
           
Total operating expenses   2,783,110    861,235 
           
Loss from operations   (1,562,465)   (158,558)
           
Other income (expenses):          
Interest income   1,458    122 
Interest expense   (11,271)   (10,828)
Other income   16,673    988 
Other expenses   (23,662)   (12,272)
Total other expenses   (16,802)   (21,990)
           
Loss before income tax provision   (1,579,267)   (180,548)
           
Income tax expense (benefit)   (816)   7,689 
           
Net loss   (1,578,451)   (188,237)
           
Less: net loss attributable to non-controlling interest   -    (4,988)
           
Net loss attributable to HeartCore Enterprises, Inc.  $(1,578,451)  $(183,249)
           
Other comprehensive income:          
Foreign currency translation adjustment   80,053    97,522 
           
Total comprehensive loss   (1,498,398)   (90,715)
Less: comprehensive loss attributable to non-controlling interest   -    (2,404)
Comprehensive loss attributable to HeartCore Enterprises, Inc.  $(1,498,398)  $(88,311)
           
Net loss per common share attributable to HeartCore Enterprises, Inc.*          
Basic  $(0.09)  $(0.01)
Diluted  $(0.09)  $(0.01)
Weighted average common shares outstanding*          
Basic   17,265,332    15,242,454 
Diluted   17,265,332    15,242,454 

 

* Retrospectively restated for effect of share issuances on July 16, 2021.

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

3

 

 

HEARTCORE ENTERPRISES, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

FOR THE THREE MONTHS ENDED MARCH 31, 2022 and 2021

 

  

Number of

shares

     Amount    

paid-in

capital*

  

 

Accumulated

deficit

  

 

comprehensive

loss

  

 

shareholders’

deficit

  

 

controlling

interest

  

 

shareholders’

deficit

 
   Common shares*   Additional       Accumulated other  

Total HeartCore

Enterprises, Inc.

   Non-   Total 
  

Number of

shares

   Amount  

paid-in

capital*

  

Accumulated

deficit

  

comprehensive

loss

  

shareholders’

deficit

  

controlling

interest

  

shareholders’

deficit

 
Balance, December 31, 2020*   15,242,454   $1,524   $2,735,315   $(3,557,957)  $(136,890)  $(958,008)  $353,825   $(604,183)
Net loss   -    -    -    (183,249)   -    (183,249)   (4,988)   (188,237)
Foreign currency translation adjustment   -    -    -    -    94,938    94,938    2,584    97,522 
Balance, March 31, 2021*   15,242,454   $1,524   $2,735,315   $(3,741,206)  $(41,952)  $(1,046,319)  $351,421   $(694,898)

 

* Retrospectively restated for effect of share issuances on July 16, 2021.

 

                                   
                         
                  Accumulated    
   Common shares   Additional     

other

comprehensive

  

Total

shareholders’

 
   Number of  shares   Amount   paid-in capital  

Accumulated

deficit

  

income

(loss)

  

equity

(deficit)

 
Balance, December 31, 2021   15,546,454   $1,554   $3,350,779   $(3,896,113)  $(15,172)  $(558,952)
Net loss   -    -    -    (1,578,451)   -    (1,578,451)
Foreign currency translation adjustment   -    -    -    -    80,053    80,053 
Issuance of common shares for cash   3,096,000    310    13,643,969    -    -    13,644,279 
Issuance of common shares from exercise of share options   273,489    27    (11)   -    -    16 
Share-based compensation   -    -    422,164    -    -    422,164 
Balance, March 31, 2022   18,915,943   $1,891   $17,416,901   $(5,474,564)  $64,881   $12,009,109 

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

4

 

 

HEARTCORE ENTERPRISES, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

     2022     2021 
  

For the Three Months Ended

March 31,

 
   2022   2021 
Cash flows from operating activities:          
Net loss  $(1,578,451)  $(188,237)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation expenses   24,889    28,070 
Amortization of debt issuance costs   866    949 
Non-cash lease expense   75,986    87,247 
Deferred income taxes   6,311    11,650 
Share-based compensation   422,164    - 
           
Changes in assets and liabilities:          
Accounts receivable, net   (217,638)   (458,314)
Prepaid expenses   (488,970)   (186,462)
Other assets   (34,896)   (29,300)
Accounts payable and accrued expenses   (79,982)   319,323 
Accrued payroll and other employee costs   (27,492)   (7,235)
Operating lease liabilities   (78,226)   (89,749)
Finance lease liabilities   (174)   (375)
Income tax payables   (10,037)   (159,991)
Deferred revenue   (295,176)   (233,170)
Other liabilities   (113,027)   54,782 
           
Net cash flows used in operating activities   (2,393,853)   (850,812)
           
Cash flows from investing activities:          
Purchases of property and equipment   (18,903)   (4,239)
Advance and loan provided to related parties   (25,480)   (60,271)
Repayment of loan provided to related party   9,102    - 
           
Net cash flows used in investing activities   (35,281)   (64,510)
           
Cash flows from financing activities:          
Proceeds from initial public offering, net of issuance cost   13,602,554    - 
Proceeds from issuance of common shares prior to initial public offering   220,572    - 
Payments for finance leases   (14,916)   (16,172)
Proceeds from long-term debt   258,087    - 
Repayment of long-term debts   (308,121)   (328,799)
Repayment of insurance premium financing   (41,280)   - 
Repayment to related party   (903)   - 
Payment of debt issuance costs   (1,030)   (1,420)
Payment for mandatorily redeemable financial interest   (430,489)   - 
           
Net cash flows provided by (used in) financing activities   13,284,474    (346,391)
           
Effect of exchange rate changes   (78,293)   (103,801)
           
Net change in cash and cash equivalents   10,777,047    (1,365,514)
           
Cash and cash equivalents - beginning of the period   3,136,839    3,058,175 
           
Cash and cash equivalents - end of the period  $13,913,886   $1,692,661 
           
Supplemental cash flow disclosure:          
Interest paid  $13,262   $13,555 
Income taxes paid  $1,489   $6,605 
           
Non-cash investing and financing transactions          
           
Payroll withheld as repayment of loan receivable from employees  $2,065   $3,679 
Expense paid by related parties on behalf of the Company  $25,480   $24,891 
Share repurchase liability settled by issuance of common shares  $16   $- 
Deferred offering costs recognized against the proceeds from the offering  $178,847   $- 
Insurance premium financing  $388,538   $- 

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

5

 

 

HEARTCORE ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS

 

HeartCore Enterprises, Inc. (“HeartCore USA” or the “Company”), a holding company, was incorporated under the laws of the State of Delaware on May 18, 2021.

 

On July 16, 2021, the Company executed a Share Exchange Agreement with certain shareholders of HeartCore Co. Ltd. (“HeartCore Japan”), a company that was incorporated in Japan on June 12, 2009. Pursuant to the terms of the Share Exchange Agreement, the Company issued 15,999,994 shares of its common shares to the shareholders of HeartCore Japan in exchange for 10,706 shares out of 10,984 shares of common shares issued by HeartCore Japan, representing approximately 97.5% of HeartCore Japan’s outstanding common shares. On February 24, 2022, the Company purchased the remaining 278 shares of common shares of HeartCore Japan. As a result, HeartCore Japan became a wholly owned operating subsidiary of the Company.

 

The share exchange on July 16, 2021 has been accounted for as a recapitalization between entities under common control since the same controlling shareholders controlled these two entities before and after the transaction. The consolidation of the Company and its subsidiary has been accounted for at historical cost and prepared on the basis as if the transaction had become effective as of the beginning of the earliest period presented in the accompanying unaudited consolidated financial statements.

 

The Company, via its wholly-owned operating subsidiary, HeartCore Japan, is mainly engaged in the business of developing and sales of comprehensive software. HeartCore USA and HeartCore Japan are hereafter referred to as the Company.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The unaudited consolidated financial statements include the accounts of the Company and its subsidiary. Prior to February 24, 2022, ownership interest of non-controlling party is presented as mandatorily redeemable financial interest or non-controlling interest as applicable. All significant intercompany accounts and transactions have been eliminated.

 

These unaudited interim consolidated financial statements do not include all of the information and disclosure required by the U.S. GAAP for complete financial statements. Interim results are not necessarily indicative of results for a full year. In the opinion of management, all adjustments consisting of normal recurring nature considered necessary for a fair presentation of the financial position and the results of operations and cash flows for the interim periods have been included. The unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the year ended December 31, 2021.

 

Use of Estimates

 

In preparing the consolidated financial statements in conformity U.S. GAAP, the management is required to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information available as of the date of the consolidated financial statements. Significant estimates required to be made by management include, but are not limited to, the allowance for doubtful accounts, useful lives of property and equipment, the impairment of long-lived assets, valuation of share-based compensation, valuation allowance of deferred tax assets, implicit interest rate of operating and financing leases, valuation of asset retirement obligations and revenue recognition. Actual results could differ from those estimates.

 

6

 

 

HEARTCORE ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

COVID-19

 

While the duration and extent of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment actions, it has already had an adverse effect on the global economy and the lasting effects of the pandemic continue to be unknown. The Company may experience customer losses, including due to bankruptcy or customers ceasing operations, which may result in delays in collections or an inability to collect accounts receivable from these customers. The extent to which COVID-19 may continue to impact the Company’s financial condition, results of operations, or liquidity continues to remain uncertain, and as of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or an adjustment to the carrying value of the Company’s assets or liabilities. These estimates may change, as new events occur and additional information is obtained, which will be recognized in the consolidated financial statements as soon as they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s financial statements.

 

Asset Retirement Obligations

 

Pursuant to the lease agreements for the office space, the Company is responsible to restore these spaces back to its original statute at the time of leaving. The Company recognizes an obligation related to these restorations as asset retirement obligation included in other non-current liabilities in the consolidated balance sheets, in accordance with the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Codification (“ASC”) 410, “Asset Retirement Obligation Accounting”. The Company capitalizes the associated asset retirement cost by increasing the carrying amount of the related property and equipment. The following table presents changes in asset retirement obligations:

   March 31,   December 31, 
   2022   2021 
Beginning balance  $155,666   $173,043 
Accretion expense   128    730 
Foreign currency translation adjustment   (7,721)   (18,107)
Ending balance  $148,073   $155,666 

 

Software Development Costs

 

Software development costs are expensed as incurred until the point the Company establishes technological feasibility. Technological feasibility is established upon completion of a detailed program design or the completion of a working model. Costs incurred by the Company between establishment of technological feasibility and the point at which the product is ready for general release are capitalized and amortized over the economic life of the related products. The Company’s software development costs incurred subsequent to achieving technological feasibility have not been significant and all software development costs have been expensed as incurred.

 

In the three months ended March 31, 2022 and 2021, software development costs expensed as incurred amounted to $108,259 and $52,146, respectively. These software development costs were included in the research and development expenses.

 

Impairment of Long-Lived Assets

 

Long-lived assets with finite lives, primarily property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the estimated cash flows from the use of the asset and its eventual disposition are below the asset’s carrying value, then the asset is deemed to be impaired and written down to its fair value. There were no impairments of these assets during the three months ended March 31, 2022 and 2021.

 

Foreign Currency Translation

 

The Company maintains its books and record in its local currency, Japanese YEN (“JPY”), which is a functional currency as being the primary currency of the economic environment in which its operation is conducted. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statements of operations.

 

7

 

 

HEARTCORE ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

The reporting currency of the Company is the United States Dollars (“US$”), and the accompanying unaudited consolidated financial statements have been expressed in US$. In accordance with ASC Topic 830-30, “Translation of Financial Statements”, assets and liabilities of the Company whose functional currency is not US$ are translated into US$, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from the translation of financial statements are recorded as a separate component of accumulated other comprehensive income (loss) within the statements of changes in shareholders’ equity (deficit).

 

Translation of amounts from the local currency of the Company into US$1 has been made at the following exchange rates:

 

  

March 31,

2022

  

March 31,

2021

 
Current JPY: US$1 exchange rate   121.83    110.70 
Average JPY: US$1 exchange rate   116.24    106.01 

 

Revenue Recognition

 

The Company recognizes revenue under ASC Topic 606, “Revenue from Contracts with customers”.

 

To determine revenue recognition for contracts with customers, the Company performs the following five steps : (i) identify the contract(s) with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation. The revenue amount represents the invoiced value, net of a value-added tax (“Consumption Tax”) and applicable local government levies. The Consumption Tax on sales is calculated at 10% of gross sales.

 

The Company currently generates its revenue from the following main sources:

 

Revenue from On-Premises Software

 

Licenses for on-premises software provide the customer with a right to use the software as it exists when made available to the customer. The Company provides on-premises software in the form of both perpetual licenses and term-based licenses which grant the customers with the right for a specified term. Revenue from on-premises licenses is recognized upfront at the point in time when the software is made available to the customer. Licenses for on-premises software are typically sold to the customer with maintenance and support services in a bundle. Revenues under the bundled arrangements are allocated based on the relative standalone selling prices (“SSP”) of on-premises software and maintenance and support service. The SSP for maintenance and support services is estimated based upon observable transactions when those services are sold on a standalone basis. The SSP of on-premises software is typically estimated using the residual approach as the Company is unable to establish the SSP for on-premises licenses based on observable prices given the same products are sold for a broad range of amounts (that is, the selling price is highly variable) and a representative SSP is not discernible from past transactions or other observable evidence.

 

Revenue from Maintenance and Support Service

 

Maintenance and support services provided with software licenses consist of trouble shooting, technical support and the right to receive unspecified software updates when and if available during the subscription. Revenues from maintenance and support services are recognized over time as such services are performed. Revenues for consumption-based services are generally recognized as the services are performed and accepted by the customers.

 

8

 

 

HEARTCORE ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

Revenue from Software as a Service (“SaaS”)

 

The Company’s software is available for use as hosted application arrangements under subscription fee agreements without licensing the rights of the software to the customers. Subscription fees from these applications are recognized over time on a ratable basis over the customer agreement term beginning on the date the Company’s solution is made available to the customer. The subscription contracts are generally one year or less in length.

 

Revenue from Software Development and other Miscellaneous Services

 

The Company provides customers with software development and support service pursuant to their specific requirements, which primarily compose of consulting, integration, training, custom application, and workflow development. The Company also provides other miscellaneous services, such as 3D Space photography. The Company generally recognized revenue at a point in time when control is transferred to the customers and the Company is entitled to the payment, which is when the promised services are delivered and accepted by the customers.

 

The timing of revenue recognition may differ from the timing of invoicing to the customers. The Company records a contract asset, which is included in accounts receivable on the consolidated balance sheets, when revenue is recognized prior to invoicing. The Company records deferred revenues on the consolidated balance sheets when revenues are recognized subsequent to cash collection for an invoice. Deferred revenues are reported net of related uncollected deferred revenues in the consolidated balance sheets. The amount of revenues recognized during the three months ended March 31, 2022 and 2021 that were included in the opening deferred revenues balance was approximately $0.8 million and $0.9 million, respectively.

 

Disaggregation of Revenue

 

The Company disaggregates its revenues from contracts by service types, as the Company believes it best depicts how the nature, amount, timing and uncertainty of the revenue and cash flows are affected by economic factors. The Company’s disaggregation of revenues by type for the three months ended March 31, 2022 and 2021 is as following:

     2022     2021 
   For the Three Months Ended 
   March 31, 
   2022   2021 
         
Revenue from On-Premise Software  $801,601   $249,608 
Revenue from Maintenance and Support Service   845,339    942,215 
Revenue from Software as a Service (“SaaS”)   126,654    151,808 
Revenue from Software Development and other Miscellaneous Services   502,407    766,678 
Total Revenue  $2,276,001   $2,110,309 

 

The Company’s disaggregation of revenues by product is as following:

 

   For the Three Months Ended 
   March 31, 
   2022   2021 
         
Revenue from Customer Experience Management Platform  $1,755,053   $1,614,356 
Revenue from Process Mining   266,488    256,784 
Revenue from Robotic Process Automation   98,386    106,679 
Revenue from Task Mining   86,877    55,799 
Revenue from Others   69,197    76,691 
Total Revenue  $2,276,001   $2,110,309 

 

As of March 31, 2022 and 2021, and for the periods then ended, all long-lived assets and almost all of the revenue generated are attributed to the Company’s operation in Japan.

 

9

 

 

HEARTCORE ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to credit risk consist primarily of accounts and other receivables. The Company does not require collateral or other security to support these receivables. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.

 

For the three months ended March 31, 2022, customer A represents 13.3% of the Company’s total revenues. For the three months ended March 31, 2021, customer B and C represents 11.9% and 10.9%, respectively, of the Company’s total revenues.

 

For the three months ended March 31, 2022, vendor A, B and C represents 36.1%, 29.4% and 10.8%, respectively, of the Company’s total purchases. For the three months ended March 31, 2021, vendor A and B represents 59.4% and 23.1%, respectively, of the Company’s total purchases.

 

Share-based Compensation

 

The Company accounts for share-based compensation awards in accordance with ASC 718, “Compensation – Stock Compensation”. The cost of services received from employees and non-employees in exchange for awards of equity instruments is recognized in the consolidated statements of operations based on the estimated fair value of those awards on the grant date and amortized on a straight-line basis over the requisite service period or vesting period. The Company records forfeitures as they occur.

 

NOTE 3 — ACCOUNTS RECEIVABLE, NET

 

Accounts receivable consists of the following:

 

     March 31,     December 31, 
   March 31,   December 31, 
   2022   2021 
Accounts receivable  $1,116,254   $960,964 
Less: allowance for doubtful accounts   -    - 
Accounts receivable, net  $1,116,254   $960,964 

 

NOTE 4 — PREPAID EXPENSES

 

Prepaid expenses consist of the following:

  

     March 31,     December 31, 
   March 31,   December 31, 
   2022   2021 
Prepayments to software vendors  $128,418   $157,060 
Prepaid selling expenses   426,972    - 
Prepaid subscription fees   50,852    53,413 
Deferred offering expenses   -    180,630 
Prepaid insurance premium   465,019    18,252 
Others   51,789    35,050 
Total  $1,123,050   $444,405 

 

10

 

 

HEARTCORE ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

Deferred offering expenses, consisting of legal fees and road show expenses relating to the Company’s planned initial public offering, are capitalized and recorded on the balance sheet. The deferred offering expenses were reclassified to shareholders’ equity and recorded against the proceeds received upon the closing of our initial public offering on February 14, 2022.

 

NOTE 5 — RELATED PARTY TRANSACTIONS

 

As of March 31, 2022 and December 31, 2021, the Company has a due to related party balance of $185 and $1,110, respectively, from Sumitaka Yamamoto, the CEO and major shareholder of the Company. The balance is unsecured, non-interest bearing and due on demand. During the three months ended March 31, 2022 and 2021, the Company advanced $25,480 and $3,075, respectively, to this related party, and the related party paid expenses of $25,480 and $10,695, respectively, on behalf of the Company. The Company also repaid $903 to the related party during the three months ended March 31, 2022.

 

As of March 31, 2022 and December 31, 2021, the Company has a loan receivable balance of $356,268 and $386,315, respectively, from Heartcore Technology Inc., a company controlled by the CEO of the Company. The loan was made to the related party to support its operation. The balance is unsecured, bears an annual interest of 1.475%, and requires repayments in installments starting from February 2022. During the three months ended March 31, 2022 and 2021, the Company loaned nil and $57,195, respectively, to this related party, and the related party paid expenses of nil and $14,197, respectively, on behalf of the Company. During the three months ended March 31, 2022 and 2021, the Company received repayments of $9,102 and nil, respectively, from this related party.

 

In June 2020, Suzuyo Shinwart Corporation became an over 10% shareholder of the Company. During the three months ended March 31, 2021, the Company has revenue from this related party of $73,569 from software sales and incurred cost with this related party of $185,875 for software development services provided. As of March 31, 2021, the Company has deferred revenue and other payable with this related party of $36,012 and $181,328, respectively. In July 2021, Suzuyo Shinwart Corporation sold all its shares of the Company to the Company’s CEO and ceased to be the Company’s related party.

 

During the period from January 1, 2022 through January 13, 2022, the Company completed a private placement, in which, it issued 30,000 shares of common shares at a purchase price of $2.50 per share to the officers of the Company for an aggregate amount of $75,000.

 

NOTE 6 — PROPERTY AND EQUIPMENT, NET

 

Property and equipment consist of the following:

 

   March 31,   December 31, 
   2022   2021 
Leasehold improvement  $302,547   $320,257 
Machinery and equipment   314,220    316,126 
Vehicle   114,531    121,235 
Software   175,362    185,627 
Subtotal   906,660    943,245 
Accumulated depreciation   (667,873)   (681,831)
Property and equipment, net  $238,787   $261,414 

 

Depreciation expense was $24,889 and $28,070 for the three months ended March 31, 2022 and 2021, respectively.

 

NOTE 7 — LEASES

 

The Company has entered into two leases for its office space, which were classified as operating leases. It has also entered into two leases for office equipment and a lease for a vehicle, and these leases were classified as finance leases. Right-of-use assets of these finance leases in the amount of $42,054 and $57,167 are included in property and equipment as of March 31, 2022 and December 31, 2021, respectively.

 

11

 

 

HEARTCORE ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

The components of lease costs are as follows:

 

     2022     2021 
   For the Three Months Ended 
   March 31, 
   2022   2021 
Finance lease costs          
Amortization of right-of-use assets  $12,526   $13,735 
Interest on lease liabilities   174    375 
Total finance lease costs   12,700    14,110 
Operating lease costs   87,051    101,474 
Total lease costs  $99,751   $115,584 

 

The following table presents supplemental information related to the Company’s leases:

 

     2022     2021 
   For the Three Months Ended 
   March 31, 
   2022   2021 
Cash paid for amounts included in the measurement of lease liabilities:        
Operating cash flows from finance leases  $174   $375 
Operating cash flows from operating leases   89,290    103,815 
Financing cash flows from finance leases   14,916    16,172 
           
Weighted average remaining lease term (years)          
Finance leases   1.4    2.1 
Operating leases   9.9    10.9 
           
Weighted-average discount rate: (per annum)          
Finance leases   1.32%   1.32%
Operating leases   1.32%   1.32%

 

As of March 31, 2022, the future maturity of lease liabilities is as follows:

 

Year ending December 31,  Finance lease   Operating lease 
Remaining of 2022  $22,755   $255,580 
2023   20,947    340,773 
2024   308    340,773 
2025   -    340,773 
2026   -    340,773 
Thereafter   -    1,743,870 
Total lease payments   44,010    3,362,542 
Less: imputed interest   (313)   (217,181)
Total lease liabilities   43,697    3,145,361 
Less: current portion   29,272    313,737 
Non-current lease liabilities  $14,425   $2,831,624 

 

Pursuant to the operating lease agreements, the Company made security deposits to the lessors. The security deposits amounted to $262,851 and $278,237 as of March 31, 2022 and December 31, 2021, respectively.

 

12

 

 

HEARTCORE ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 8 — LONG-TERM DEBTS

 

The Company’s long-term debts included bond payable and loans borrowed from banks and other financial institutions, which consist of the following:

 

Name of Financial Institutions  Original Amount Borrowed (JPY)  

Loan

Duration

 

Annual

Interest Rate

  

Balance as of

March 31,

2022

  

Balance as of

December 31,

2021

 
Bond payable                       
Corporate bond issued through Resona Bank   

100,000,000

(a)(b) 

1/10/2019—

1/10/2024

   0.430%  $328,326   $434,431 
Loans with banks and other financial institutions                       
Resona Bank, Limited.   30,000,000(a) 

12/29/2017—

12/30/2022

   1.475%   36,937    56,476 
Resona Bank, Limited.   

50,000,000

(a)(b) 

12/29/2017—

12/29/2024

   0.675%   161,331    191,454 
Resona Bank, Limited.   

10,000,000

(a)(b) 

9/30/2020—

9/30/2027

   0.000%   64,500    72,411 
Resona Bank, Limited.   

40,000,000

(a)(b) 

9/30//2020—

9/30/2027

   0.000%   257,999    289,644 
Resona Bank, Limited.   

20,000,000

(a)(b) 

11/13/2020—

10/31/2027

   1.600%  130,953    146,890 
Sumitomo Mitsui Banking Corporation   100,000,000  

12/28/2018—

12/28/2023

   1.475%   287,179    361,925 
Sumitomo Mitsui Banking Corporation   10,000,000(b) 

12/30/2019—

12/30/2026

   1.975%   55,709    63,105 
The Shoko Chukin Bank, Ltd.   30,000,000  

9/28/2018—

8/31/2023

   1.200%   70,426    92,273 
The Shoko Chukin Bank, Ltd.   50,000,000  

7/27/2020—

6/30/2027

   1.290%   311,910    351,020 
Japan Finance Corporation   40,000,000  

12/15/2017—

11/30/2022

   0.300%   47,854    73,940 
Japan Finance Corporation   80,000,000  

11/17/2020—

11/30/2027

   0.210%   538,455    603,339 
Higashi-Nippon Bank   30,000,000(a)  3/31/2022 – 3/31/2025   1.400%   246,245    - 
Aggregate outstanding principal balances                2,537,824    2,736,908 
Less: unamortized debt issuance costs                (13,660)   (15,333)
Less: current portion                (847,316)   (849,995)
Non-current portion               $1,676,848   $1,871,580 

 

  (a) These debts are guaranteed by Sumitaka Yamamoto, the Company’s CEO and major shareholder.
  (b) These debts are guaranteed by Tokyo Credit Guarantee Association, and the Company has paid guarantee expenses for these debts.

 

In March 2022, the Company entered into a loan agreement with Higashi-Nippon Bank with a term of three years payable monthly. The loan is guaranteed by Sumitaka Yamamoto, the Company’s CEO and major shareholder.

 

Interest expense for long-term debts was $7,016 and $10,828 for the three months ended March 31, 2022 and 2021, respectively.

 

13

 

 

HEARTCORE ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

As of March 31, 2022, future minimum loan payments are as follows:

Year ending December 31,  Loan 
   Payment 
Remaining of 2022  $569,006 
2023   767,586 
2024   475,901 
2025   273,036 
2026   248,436 
Thereafter   203,859 
Total  $2,537,824 

 

NOTE 9 — INSURANCE PREMIUM FINANCING

 

In February 2022, the Company entered into an insurance premium financing agreement with BankDirect Capital Finance for $388,538 at an annual interest rate of 12.80% for nine months from February 1, 2022, payable in nine monthly installments of principal and interest. As of March 31, 2022, the balance of the insurance premium financing was $347,258. During the three months ended March 31, 2022, the interest incurred was $4,255.

 

NOTE 10 — INCOME TAXES

 

United States

 

HeartCore USA is a holding company registered in the State of Delaware incorporated in May 2021. The U.S. federal income tax rate is 21%.

 

Japan

 

The Company conducts its major businesses in Japan and is subject to tax in this jurisdiction. As a result of its business activities, the Company files tax returns that are subject to examination by the local tax authority. Income taxes in Japan applicable to the Company are imposed by the national, prefectural, and municipal governments, and in the aggregate resulted in an effective statutory rate of approximately 30.62% for the three months ended March 31, 2022 and 2021.

 

For the three months ended March 31, 2022 and 2021, the Company’s income tax expenses (benefits) are as follows:

 

     2021     2020 
   For the Three Months Ended 
   March 31, 
   2022   2021 
Current  $(774)  $(1,368)
Deferred   (42)   9,057 

Income tax expense (benefits)

  $(816)  $7,689 

 

The effective tax rate was 0.05% and (4.26)% for the three months ended March 31, 2022 and 2021, respectively.

 

NOTE 11 – SHARE-BASED COMPENSATION

 

Options

 

In May 2016, the Company granted 507 units stock options to its employees each to acquire one share of common shares of HeartCore Japan (an equivalent of approximately 1,494 shares of common shares of HeartCore USA) at JPY10 each (approximately $0.09). All options are exercisable upon issuance with a repurchase provision before the completion of the Company’s initial public offering, which serves as a vesting condition. All employees that were granted these stock options had early exercised their stock options in 2016 prior to the vesting of the related stock options. As of March 31, 2021, 324 units of the options were forfeited, and the CEO of the Company has repurchased and held the shares issued related to the early exercise of such stock options on behalf of the Company. On November 3, 2021, the Company redeemed 484,056 shares (equivalent to 324 shares of common shares of HeartCore Japan) from the CEO of the Company.

 

14

 

 

HEARTCORE ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

The consideration received for the remaining early exercised options were recorded by the Company as a share repurchase liability included in other current liabilities in the consolidated balance sheet with JPY1,830 (approximately $16) as of December 31, 2021. The shares issued related to the early exercise of the above-mentioned stock options were not considered outstanding as of December 31, 2021. On February 14, 2022, the 183 units of stock options were vested upon the completion of the Company’s initial public offering and the Company recognized share-based compensation of $11,005 during the three months ended March 31, 2022. In the same period, the share repurchase liability of $16 was settled by issuance of 273,489 shares of common shares (equivalent to 183 shares of common shares of HeartCore Japan) from exercise of stock options.

 

The following summarized the Company’s stock option activity for the stock options issued in 2016 for the three months ended March 31, 2022 and 2021:

 

     Number of stock options 
   Number of stock options 
Issued and unvested as of January 1, 2021   194 
Forfeited   11 
Issued and unvested as of March 31, 2021   183 
      
Issued and unvested as of January 1, 2022   183 
Vested and exercised   183 
Issued and unvested as of March 31, 2022   - 

 

The following table summarizes the share options activity and related information for the three months ended March 31, 2022:

 

   Number of Options/ Warrants   Weighted Average Exercise Price  

Weighted Average Remaining Term

(Years)

   Intrinsic Value 
As of January 1, 2022   1,534,500   $2.5    9.99    - 
Granted   -    -    -    - 
Forfeited   -          -    -    - 
Exercised   -    -    -    - 
As of March 31, 2022   1,534,500   $2.5    9.74   $583,110 
Vested and exercisable as of March 31, 2022   -    -    -    - 

 

Options granted historically were valued using the binomial model with the assistance of an independent valuation specialist. Significant assumptions used in the valuation include expected volatility, risk-free interest rate, dividend yield and expected exercise term.

 

For the three months ended March 31, 2022 and 2021, share-based compensation related to the options totaled $292,812 and nil, respectively. The outstanding unamortized share-based compensation related to options was $1,912,528 (which will be recognized through December 2025) as of March 31, 2022.

 

15

 

 

HEARTCORE ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

Restricted Stock Units (“RSUs”)

 

The following table summarizes the RSUs activity for the three months ended March 31, 2022: 

 

    

Number of RSUs

 
Issued as of January 1, 2022   - 
Granted   169,153 
Forfeited   - 
Issued as of March 31, 2022   169,153 
Vested as of March 31, 2022   - 

 

On February 9, 2022, the Company entered into executive employment agreements with five executives and granted 85,820 RSUs pursuant to the 2021 Equity Incentive Plan. The RSUs vest on each annual anniversary of the date of the employment agreement, in an amount equal to 25% of the applicable shares of common shares. The fair value of the RSUs at grant date was $424,809.

 

On February 25, 2022, the Company entered into a service agreement with a marketing company to purchase 6-month marketing services and granted 83,333 RSUs. The RSUs were issued and vested on May 15, 2022. The fair value of the RSUs at grant date was $224,999.

 

For the three months ended March 31, 2022, the Company recognized RSU-related share-based compensation of $129,352. The outstanding unamortized share-based compensation related to RSUs was $520,456 (which will through February 2026) as of March 31, 2022.

 

NOTE 12 – SHAREHOLDERS’ EQUITY (DEFICIT)

 

The Company was authorized to issue 200,000,000 shares of common shares, par value of $0.0001 per share, and 20,000,000 shares of preferred shares, par value of $0.0001 per share.

 

During the period from January 1, 2022 through January 13, 2022, the Company issued 96,000 shares of common shares at a purchase price of $2.50 per share for an aggregate net proceeds of $220,572 in a private placement, including 30,000 shares of common shares issued to the officers of the Company.

 

On February 14, 2022, the Company completed its initial public offering on the NASDAQ Capital Market under the symbol of “HTCR”. The Company offered 3,000,000 common shares at $5.00 per share. Net proceeds raised by the Company from the initial public offering amounted to $13,724,167 after deducting underwriting discounts and commissions and other offering expenses. The Company has deferred costs of $300,460 directly attributed to the offering, among which $178,847 offering costs were paid and deferred as of December 31, 2021. Those costs were also charged against the proceeds from the offering.

 

On February 14, 2022, 273,489 shares of common shares were issued from exercise of stock options by settling share repurchase liability of $16 (also see NOTE 11).

 

As of March 31, 2022 and December 31, 2021, there were 18,915,943 and 15,819,943 shares, respectively, of common shares issued; and 18,915,943 and 15,546,454 shares, respectively, of common shares outstanding.

 

No preferred shares were issued and outstanding as of March 31, 2022 and December 31, 2021.

 

NOTE 13 – MANDATORILY REDEEMABLE FINANCIAL INTEREST

 

On August 10, 2021, the Company and Dentsu Digital Investment Limited (“Dentsu Digital”), a non-controlling shareholder of HeartCore Japan, entered into a stock purchase agreement, pursuant to which the Company has agreed to purchase the 278 shares of HeartCore Japan held by Dentsu Digital in accordance with certain terms and conditions in the stock purchase agreement for JPY50,040,000 on the earlier of the (i) the date the SEC declares effective a registration statement on Form S-1, for a firm commitment underwritten initial public offering of common shares, filed by the Company with the SEC or (ii) December 20, 2022. The Company has determined such shares to be a mandatorily redeemable financial instrument and is recorded as a liability of JPY50,040,000 (approximately $448,000) in the consolidated balance sheet as of December 31, 2021. On February 24, 2022, the Company purchased the 278 shares of HeartCore Japan from Dentsu Digital for JPY50,040,000 (approximately $430,000). As a result, HeartCore Japan became a wholly-owned subsidiary of the Company.

 

16

 

 

HEARTCORE ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 14 –LOSS PER SHARE

 

Basic loss per share is calculated on the basis of weighted-average outstanding common shares. Diluted loss per share is computed on the basis of basic weighted-average outstanding common shares adjusted for the dilutive effect of stock options, restricted stock unit awards and other dilutive securities.

 

The computation of basic and diluted loss per share for the three months ended March 31, 2022 and 2021 is as follows:

 

     2022     2021 
   For the Three Months Ended 
   March 31, 
   2022   2021 

Loss per share – basic 

          
Numerator:          
Allocation of net loss attributable to HeartCore Enterprises, Inc.’s common shareholders used in calculating loss per common share — basic  $(1,578,451)  $(183,249)
Net loss attributable to common shareholders  (1,578,451)  (183,249)
Denominator:          
Weighted average number of common shares outstanding used in calculating basic loss per share   17,265,332    15,242,454 
Denominator used for loss per share   17,265,332    15,242,454 
Loss per share — basic  $(0.09)  $(0.01)

 

   For the Three Months Ended 
   March 31, 
   2022   2021 

Loss per share – diluted

          
Numerator:          
Allocation of net loss attributable to HeartCore Enterprises, Inc.’s common shareholders used in calculating loss per common share — diluted  $(1,578,451)  $(183,249)
Net loss attributable to common shareholders   (1,578,451)   (183,249)
Denominator:          
Weighted average number of common shares outstanding used in calculating diluted loss per share   17,265,332    15,242,454 
Denominator used for loss per share   17,265,332    15,242,454 
Loss per share — diluted  $(0.09)  $(0.01)

 

For the three months ended March 31, 2022 and 2021, the weighted average shares outstanding is the same for basic and diluted loss per share calculations, as the inclusion of common shares equivalents of 273,489 and 1,703,653, respectively, would have an anti-dilutive effect.

 

NOTE 15 - SUBSEQUENT EVENTS

 

On February 25, 2022, the Company entered into a service agreement with a marketing company pursuant to which the Company agreed to issue 83,333 RSUs for 6-month marketing services to be provided from February 25, 2022 to August 26, 2022. The RSUs were issued on May 15, 2022.

 

17

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The Private Securities Litigation Reform Act of 1995 and Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), provide a safe harbor for forward-looking statements made by or on behalf of HeartCore Enterprises, Inc. (the “Company”). The Company and its representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this report and other filings with the Securities and Exchange Commission (“SEC”) and in our reports and presentations to stockholders or potential stockholders. In some cases, forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties can be found in Part I, Item 1A, “Risk Factors,” of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as the same may be updated from time to time, including in Part II, Item 1A, “Risk Factors,” of this Quarterly Report on Form 10-Q.

 

Although we believe the expectations reflected in our forward-looking statements are based upon reasonable assumptions, it is not possible to foresee or identify all factors that could have a material effect on the future financial performance of the Company. The forward-looking statements in this report are made on the basis of management’s assumptions and analyses, as of the time the statements are made, in light of their experience and perception of historical conditions, expected future developments and other factors believed to be appropriate under the circumstances.

 

Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained in this Quarterly Report on Form 10-Q and the information incorporated by reference in this report to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based.

 

Business Overview

 

We are a leading software development company based in Tokyo, Japan. We provide software through two business units. The first business unit includes a customer experience management business that has been in existence for 12 years. Our customer experience management platform (the “CXM Platform”) includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. We also provide education, services and support to help customers be successful with our CXM Platform.

 

The second business unit is a digital transformation business which provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. We also have an ongoing technology innovation team to develop software that supports the narrow needs of large enterprise customers.

 

We have made significant investments in our sales and marketing efforts globally. As of March 31, 2022, our sales and marketing organization was comprised of 15 employees including our field sales organization, which maintains a physical sales presence in the Japanese software market. Using our go-to-market strategy, we believe we have made significant contributions in Japan and have established a diversified revenue and customer base. As of March 31, 2022, our combined business units (customer experience management business unit and digital transformation business unit) had a total of 858 customers in Japan.

 

We were incorporated in the State of Delaware on May 18, 2021. We conduct business activities principally through our wholly-owned subsidiary, HeartCore Co., Ltd., a Japanese corporation (“HeartCore Co”), which was established in Japan by Mr. Sumitaka Yamamoto, our CEO, in 2009. We acquired 97.5% of the equity interest of HeartCore Co in July 2021 and acquired the remaining interest in February 2022. HeartCore Co started out with helping companies effectively managing content with its powerful content management system. Since then, HeartCore Co has expanded offerings to help companies manage all forms of business processes.

 

18

 

 

The acquisition of HeartCore Co in July 2021 was accounted for as a recapitalization among entities under common control since the same controlling shareholders controlled all these entities before and after the transaction. The consolidation of the Company and its subsidiaries has been accounted for at historical cost and prepared on the basis as if the transaction had become effective as of the beginning of the first period presented in the accompanying consolidated financial statements.

 

Recent Developments

 

Moveaction Consulting Agreement

 

On March 31, 2022, we entered into a Consulting and Services Agreement (the “Moveaction Consulting Agreement”) by and between the Company and Moveaction Co., Ltd. (“Moveaction”). Pursuant to the terms of the Moveaction Consulting Agreement, the Company agreed to provide Moveaction certain services, including the following (collectively, the “Services”):

 

  Assistance with the selection and negotiation of terms for a law firm, underwriter and auditing firm;
     
  Provision of process mining and task mining licenses for internal audit and internal control;
     
  Assisting in the preparation of documentation for internal controls required for an initial public offering by Moveaction on the NASDAQ Stock Market, the New York Stock Exchange or the NYSE American;
     
  Providing support services to remove problematic accounting accounts upon listing support;
     
  Translation of requested documents into English;
     
  Attend and, if requested by the other party, lead, meetings of management and employees;
     
  Provide support services related to the NASDAQ listing;
     
  Conversion of accounting data from Japanese standards to U.S. GAAP;
     
  Assist in the preparation of S-1 or F-1 filings;
     
  Creation of English web page; and
     
  Preparing an investor presentation/deck and executive summary of the operations.

 

In providing the Services, the Company will not perform accounting services, and will not act as an investment advisor or broker/dealer. Pursuant to the terms of the Consulting Agreement, the parties agreed that the Company will not provide the following services, among others: negotiation of the sale of Moveaction’s securities; participation in discussions between Moveaction and potential investors; assisting in structuring any transactions involving the sale of Moveaction’s securities; pre-screening of potential investors; due diligence activities; and providing advice relating to valuation of or financial advisability of any investments in Moveaction.

 

Pursuant to the terms of the Consulting Agreement, Moveaction agreed to compensate the Company as follows in return for the provision of Services during the initial term of nine months:

 

  (a) $460,000, to be paid as follows: (i) $180,000 on March 31, 2022; (ii) $140,000 on the three-month anniversary of March 31, 2022; and (iii) $140,000 on the six-month anniversary of March 31, 2022; and
     
  (b) Issuance by Moveaction to the Company of a warrant (the “Moveaction Warrant”) to acquire shares of Moveaction capital stock.

 

19

 

 

During any Renewal Term (as defined below), Moveaction will compensate the Company for Services at the rate of $150 per hour.

 

The Moveaction Consulting Agreement has an initial term of nine months, which will automatically renew for additional nine month period (each, a “Renewal Term”) unless either party provides at least 30 days’ prior notice.

 

As provided in the Moveaction Consulting Agreement, on the Effective Date, Moveaction issued to the Company the Moveaction Warrant. Pursuant to the terms of the Moveaction Warrant, the Company may, at any time on or after the date that Moveaction completes its first initial public offering of stock in the United States resulting in any class of Moveaction’s stock being listed for trading on any tier of the Nasdaq Stock Market, the New York Stock Exchange or the NYSE American (the “IPO Date”) and on or prior to the close of business on the tenth anniversary of the IPO Date, exercise the Moveaction Warrant to purchase eight shares of Moveaction common stock for an exercise price per share of $0.01, subject to adjustment as provided in the Moveaction Warrant. The Warrant contains a 9.99% equity blocker.

 

A.L.I. Consulting Agreement

 

On April 13, 2022, the Company entered into a Consulting and Services Agreement (the “ALI Consulting Agreement”) by and between the Company and A.L.I. Technologies Inc. (“ALI”). Pursuant to the terms of the ALI Consulting Agreement, the Company agreed to provide consultant services to assist ALI to exposure to the US stock market.

 

Pursuant to the terms of the ALI Consulting Agreement, the parties agreed that the Company will provide the following services, among others: negotiation of the sale of ALI’s securities; participation in discussions between ALI and potential investors; assisting in structuring any transactions involving the sale of ALI’s securities; pre-screening of potential investors; due diligence activities; providing advice relating to valuation of or financial advisability of any investments in ALI.

 

Pursuant to the terms of the ALI Consulting Agreement, ALI agreed to compensate the Company as follows in return for the provision of Services during the six-month term (the “Term”):

 

  (a) $400,000, to be paid as follows: (i) $200,000 on April 13, 2022; (ii) $100,000 on the three-month anniversary of April 13, 2022; and (iii) $100,000 on the six-month anniversary of April 13, 2022; and
  (b) Issuance by ALI to the Company of a warrant (the “ALI Warrant”) to acquire a number of shares of capital stock of ALI, to initially be equal to 1% of the fully diluted share capital of ALI as of April 13, 2022, subject to adjustment as set forth in the ALI Warrant.

 

For any services performed by the Company beyond the Term, ALI will compensate the Company for Services at the rate of $150 per hour.

 

The ALI Consulting Agreement has a term of six months, which shall expire unless renewed upon mutual written agreement of the parties.

 

As provided in the ALI Consulting Agreement, on April 13, 2022, ALI issued to the Company the ALI Warrant. Pursuant to the terms of the ALI Warrant, the Company may, at any time on or after the IPO Date and on or prior to the close of business on the tenth anniversary of the IPO Date, exercise the ALI Warrant to purchase 1% of the fully diluted share capital of ALI as of April 13, 2022 for an exercise price per share of $0.01, subject to adjustment as provided in the ALI Warrant. The number of shares for which the ALI Warrant will be exercisable will be automatically adjusted on the IPO Date to be 1% of the fully diluted number and class of shares of capital stock of ALI as of the IPO Date that are listed for trading. The Warrant contains a 9.99% equity blocker.

 

Going forward, we expect that we will offer services substantially similar to the Services to other third parties, as well.

 

Financial Overview

 

For the three months ended March 31, 2022 and 2021, we generated revenues of $2,276,001 and $2,110,309, respectively, and reported net losses of $1,578,451 and $188,237, respectively, and cash out flow used in operating activities of $2,393,853 and $850,812, respectively. As noted in our unaudited consolidated financial statements, as of March 31, 2022, we had an accumulated deficit of $5,474,564.

 

20

 

 

Results of Operations

 

Comparison of Results of Operations for the Three Months ended March 31, 2022 and 2021

 

The following table summarizes our operating results as reflected in our unaudited statements of operations during the three months ended March 31, 2022 and 2021, respectively, and provides information regarding the dollar and percentage increase or (decrease) during such periods.

 

   For the Three Months ended March 31, 
   2022   2021   Variance 
       % of       % of         
   Amount   revenue   Amount   revenue   Amount   % of 
                         
REVENUES  $2,276,001    100.0%  $2,110,309    100.0%  $165,692    7.9%
COST OF REVENUES   1,055,356    46.4%   1,407,632    66.7%   (352,276)   -25.0%
GROSS PROFIT   1,220,645    53.6%   702,677    33.3%   517,968    73.7%
                               
Operating expenses                              
Selling expenses   205,918    9.0%   46,341    2.2%   159,577    344.4%
General and administrative expenses   2,468,933    108.5%   762,748    36.1%   1,706,185    233.7%
Research and development expenses   108,259    4.8%   52,146    2.5%   56,113    107.6%
Total operating expenses   2,783,110    122.3%   861,235    40.8%   1,921,875    223.2%
                               
Loss from operations   (1,562,465)   -68.7%   (158,558)   -7.5%   (1,403,907)   885.4%
                               
Other expenses   (16,802)   -0.7%   (21,990)   -1.0%   5,188    -23.6%
                               
Loss before income tax provision   (1,579,267)   -69.4%   (180,548)   -8.5%   (1,398,719)   774.7%
                               
Income tax expense (benefit)   (816)   0.0%   7,689    0.4%   (8,505)   -110.6%
                               
Net loss   (1,578,451)   -69.4%   (188,237)   -8.9%   (1,390,214)   738.5%
                               
Less: net loss attributable to non-controlling interest   -    -%   (4,988)   -0.2%   4,988    -100.0%
                               
NET LOSS ATTRIBUTABLE TO HEARTCORE ENTERPRISES, INC.  $(1,578,451)   -69.4%  $(183,249)   -8.7%  $(1,395,202)   761.4%

 

21

 

 

    For the Three Months ended March 31,  
    2022     2021     Variance  
          % of           % of              
    Amount     total
revenue
    Amount     total
revenue
    Amount     % of  
                                     
Revenues                                                
Revenue from on-premise software   $ 801,601       35.2 %   $ 249,608       11.8 %   $ 551,993       221.1 %
Revenue from maintenance and support services     845,339       37.1 %     942,215       44.7 %     (96,876 )     -10.3 %
Revenue from software as a service (“SaaS”)     126,654       5.6 %     151,808       7.2 %     (25,154 )     -16.6 %
Revenue from software development and other miscellaneous services     502,407       22.1 %     766,678       36.3 %     (264,271 )     -34.5 %
Total revenue     2,276,001       100.0 %     2,110,309       100.0 %     165,692       7.9 % 
                                                 
Cost of Revenue                                                
Costs of on-premise software     220,432       9.7 %     282,252       13.4 %     (61,820 )     -21.9 %
Costs of maintenance and support services     308,286       13.6 %     331,817       15.7 %     (23,531 )     -7.1 %
Costs of software as a service (“SaaS”)     70,924       3.1 %     115,541       5.5 %     (44,617 )     -38.6 %
Costs of software development and other miscellaneous services     455,714       20.0 %     678,022       32.1 %     (222,308 )     -32.8 %
Total cost of revenue     1,055,356       46.4 %     1,407,632       66.7 %     (352,276 )     -25.0 %
                                                 
Gross Profit                                                
On-premise software     581,169       25.5 %     (32,644     -1.5 %     613,813       -1,880.3 %
Maintenance and support services     537,053       23.6 %     610,398       28.9 %     (73,345     -12.0 %
Software as a service (“SaaS”)     55,730       2.4 %     36,267       1.7 %     19,463       53.7 %
Software development and other miscellaneous services     46,693       2.1 %     88,656       4.2 %     (41,963 )     -47.3 %
Total gross profit   $ 1,220,645       53.6 %   $ 702,677       33.3 %   $ 517,968       73.7 % 

 

22

 

 

Revenues

 

Our total revenues increased by $165,692, or 7.9%, to $2,276,001 for the three months ended March 31, 2022 from $2,110,309 for the three months ended March 31, 2021. The increase in our revenues was attributable to the following reasons:

 

(i) the revenues from sales of on-premise software increased by $551,993, or 221.1%, to $801,601 for the three months ended March 31, 2022 from $249,608 for the three months ended March 31, 2021, mainly attributable to the increased sales volume of 15 in CMS licenses;
   
(ii) Offset by the revenues from maintenance and support services decreased by $96,876, or 10.3%, to $845,339 for the three months ended March 31, 2022 from $942,215 for the three months ended March 31, 2021, mainly attributable to the depreciation of Japanese Yen, without which, the sales would have slightly decreased by $15,301, or 1.5%.
   
(iii) Offset by the decrease of $264,271, or 34.5% in our revenue from software development and other service, to $502,407 in the three months ended March 31, 2022 from $766,678 in the three months ended March 31, 2021. An important customer who contributed $229,035 to our revenue in the three months ended March 31, 2021, was finished in the prior year and accordingly generated no revenue in the current period

 

Cost of Revenues

 

Our total costs of revenues decreased by $352,276, or 25.0%, to $1,055,356 for the three months ended March 31, 2022 from $1,407,632 for the three months ended March 31, 2021. The decrease in our costs was attributable to the following reasons:

 

(i) the costs of on-premises software decreased by $61,820, or 21.9%, to $220,432 for the three months ended March 31, 2022 from $282,252 for the three months ended March 31, 2021. In addition to the depreciation of the yen, CMS license costs were fixed monthly and not proportional to sales. On the other hand, the sales deceased in the three months ended March 31, 2022 for process mining products, the costs of which were proportional to sales, resulting in a decrease in cost of sales.
   
(ii) the costs of SaaS decreased by $44,617, or 38.6%, to $70,924 for the three months ended March 31, 2022 from $115,541 for the three months ended March 31, 2021. There were specialized supporting employees and subcontractors for CXM Cloud (SaaS) in the first quarter of 2021. As the product entered into a mature phase and operations became stable in 2022, specialized supporting employees and subcontractors were no longer needed, and the costs decreased accordingly.
   
(iii) the costs of software development and other miscellaneous services decreased by $222,308, or 32.8%, to $455,714 for the three months ended March 31, 2022 from $678,022 for the three months ended March 31, 2021. As mentioned above, we incurred development costs for the product sold to the important customer in the first quarter 2021, and we incurred no such costs in 2022 because the project development completed in 2021.

 

23

 

 

Gross Profit

 

Our total gross profit increased by $517,968, or 73.7%, to $1,220,645 for the three months ended March 31, 2022 from $702,677 for the three months ended March 31, 2021. The increase in our gross profit was attributable to the gross profit from sales of on-premises software increased by $613,813, or -1,880.3% from -$32,644 for the three months ended March 31, 2021 to $581,169 for the three months ended March 31, 2022, primarily due to the increased sales in CMS licenses, the costs of which is not proportional to sales, but fixed monthly.

 

For the reasons discussed above, our overall gross profit margin increased by 20.3% to 53.6% in the three months ended March 31, 2022 from 33.3% in the three months ended March 31, 2021.

 

Operating Expenses

 

The following table sets forth the breakdown of our operating expenses for the three months ended March 31, 2022 and 2021:

 

   For the Three Months ended March 31, 
   2022   2021   Variance 
       % of       % of         
   Amount   revenue   Amount   revenue   Amount   % of 
                         
Total revenues  $2,276,001    100.0%  $2,110,309    100.0%  $165,692    7.9%
Operating expenses                              
Selling expenses   205,918    9.0%   46,341    2.2%   159,577    344.4%
General and administrative expenses   2,468,933    108.5%   762,748    36.1%   1,706,185    223.7%
Research and development expenses   108,259    4.8%   52,146    2.5%   56,113    107.6%
Total operating expenses  $2,783,110    122.3%  $861,235    40.8%  $1,921,875    223.2%

 

Selling Expenses

 

Our selling expenses primarily include advertising expenses, sales commissions, and sales promotion expenses.

 

Our selling expenses increased by $159,577, or 344.4%, to $205,918 in the three months ended March 31, 2022 from $46,341 in the three months ended March 31, 2021, primarily attributable to an increase in advertising expenses by $157,270, or 527.8%, to 187,070 in the three months ended March 31, 2022 from $29,800 in the three months ended March 31, 2021. The U.S. parent company launched advertising activities to increase its visibility in the U.S. after the Company going public in the U.S.

 

As a percentage of revenues, our selling expenses accounted for 9.0% and 2.2% of our total revenue for the three months ended March 31, 2022 and 2021, respectively.

 

24

 

 

General and Administrative Expenses

 

Our general and administrative expenses primarily consist of employee salaries and welfare, consulting and professional service fees incurred for company reorganization and going public, depreciation and amortization expenses, rental expenses, office, utility and other expenses, listing-related expenses, travel and entertainment expenses, and share-based compensation expense.

 

Our general and administrative expenses increased by $1,706,185 or 223.7%, to $2,468,933 in the three months ended March 31, 2022 from $762,748 in the three months ended March 31, 2021, primarily attributable to (i) our office, utility and other expenses increased by $121,627 or 149.0%, to $203,257 in the three months ended March 31, 2022 from $81,630 in the three months ended March 31, 2021, primarily due to the increase in the U.S. parent company’s office expenses, and D&O indemnity insurance premiums of the parent company; (ii) our consulting and professional fees increased by $412,713 or 399.3%, to $516,072 in the three months ended March 31, 2022 from $103,359 in the three months ended March 31, 2021, primarily due to the increase in consulting and legal fees related to going public; (iii) an increase in listing-related expenses of $283,468, or 100%, as compared the prior period; (iv) an increase in salaries and welfare by $384,388, or 79.8%, to $866,207 in the three months ended March 31, 2022 from $481,819 in the three months ended March 31, 2021, primarily due to the salaries paid to the parent company’s newly hired U.S. employees. In addition, the company paid approximately $150,000 in executive bonuses in the first quarter 2022; (v) an increase in share-based compensation of $422,164, or 100%, to $422,164 in the three months ended March 31, 2022 from nil in the three months ended March 31, 2021, primarily due to the amortization of fair value of stock options and restricted stock units granted.

 

The overall increase in our general and administrative expenses in three months ended March 31, 2021 as compared to the three months ended March 31, 2020 reflected the above-mentioned factors combined. As a percentage of revenues, general and administrative expenses were 108.5% and 36.1% of our revenue for the three months ended March 31, 2022 and 2021, respectively.

 

Research and development expenses

 

Our research and development expenses primarily consist of employee salaries and welfare, and outsourcing expenses.

 

25

 

 

Our research and development expenses increased by $56,113 or 107.6%, to $108,259 in the three months ended March 31, 2022 from $52,146 in the three months ended March 31, 2021, primarily attributable to an increase in outsourcing expenses by $57,302, or 126.1%, to $102,750 in the three months ended March 31, 2022 from $45,448 in the three months ended March 31, 2021, as we outsourced certain development activities for more efficiency and experience, relating to CMS UI renewal and PIM/DAM large-scale development starting in September 2021.

 

The overall increase in our research and development expenses in the three months ended March 31, 2022 as compared to the three months ended March 31, 2021 reflected the above-mentioned factors combined. As a percentage of revenues, research and development expenses were 4.8% and 2.5% of our revenue for the three months ended March 31, 2022 and 2021, respectively.

 

Other Expenses, net

 

Our other income (expenses) primarily includes interest income generated from bank deposits and loans to related-parties, interest expenses for bank loans, bonds, and leases, other incomes, and other expenses. Total other expenses, net, decreased by $5,188 or 23.6%, from $21,990 in the three months ended March 31, 2021 to $16,802 in the three months ended March 31, 2022.

 

Provision for Income Taxes

 

Our income taxes benefit was $816 in the three months ended March 31, 2022, as compared to the income taxes provision of $7,689 in the three months ended March 31, 2021, mainly due to the increased loss.

 

Net Loss

 

As a result of the foregoing, we reported a net loss of $1,578,451 for the three months ended March 31, 2022, representing a $1,390,214 or 738.5% increase from a net loss of $188,237 for the three months ended March 31, 2021.

 

Net loss attributable to non-controlling interest

 

We own 97.35% of the outstanding shares of the operation subsidiary, HeartCore Co, which located in Japan, as of March 31, 2021. Accordingly, we recorded net loss attributable to the non-controlling interest. The net loss attributable to non-controlling interest was $4,988 in the three months ended March 31, 2021.

 

On August 10, 2021, the Company and Dentsu Digital Investment Limited (“Dentsu Digital”), a non-controlling shareholder of HeartCore Japan, entered into a stock purchase agreement, pursuant to which the Company has agreed to purchase the 278 shares of HeartCore Japan held by Dentsu Digital in accordance with certain terms and conditions in the stock purchase agreement for JPY50,040,000 on the earlier of the (i) the date the SEC declares effective a registration statement on Form S-1, for a firm commitment underwritten initial public offering of common shares, filed by the Company with the SEC or (ii) December 20, 2022.

 

On February 24, 2022, the Company purchased 278 shares of HeartCore Co from Dentsu Digital for JPY50,040,000 (approximately $435,500 when paid). As a result, HeartCore Co became a wholly owned subsidiary of the Company. Accordingly, we did not record non-controlling interest income in the three months ended March 31, 2022.

 

Net loss attributable to HeartCore Enterprises, Inc.

 

As a result of the foregoing, we reported a net loss attributable to HeartCore Enterprises, Inc. of $1,578,451 for the three months ended March 31, 2022, representing a $1,395,202 or 761.4% increase from a net loss of $183,249 for the three months ended March 31, 2021.

 

Liquidity and Capital Resources

 

As of March 31, 2022, we had $13,913,886 in cash as compared to $3,136,839 as of December 31, 2021. As of March 31, 2022, our working capital was $12,526,450 as compared to $62,919 as of December 31, 2021. We also had $1,116,254 in accounts receivable as of March 31, 2022. Our accounts receivable primarily include balance due from customers for our on-premises software sold and services provided and accepted by customers.

 

26

 

 

The following table sets forth summary of our cash flows for the periods indicated:

 

   For the Three Months Ended
March 31,
 
   2022   2021 
Net cash used in operating activities  $(2,393,853)  $(850,812)
Net cash used in investing activities   (35,281)   (64,510)
Net cash provided by (used in) financing activities   13,284,474    (346,391)
Effect of exchange rate changes   (78,293)   (103,801)
Net change in cash and cash equivalents   10,777,047    (1,365,514)
Cash and cash equivalents, beginning of the period   3,136,839    3,058,175 
Cash and cash equivalents, end of the period  $13,913,886   $1,692,661 

 

Operating Activities

 

Net cash used in operating activities was $2,393,853 for the three months ended March 31, 2022, primarily consisting of the following:

 

  Net loss of $1,578,451 for the three months ended March 31, 2022.
  An increase in accounts receivable of $217,638. The increase was primarily due to the increase in our sales in the current period. The collected accounts receivable is available cash, which can be used as working capital for our business operation, if necessary.
 

An increase in prepaid expense of $488,970, primarily due to the increase in the prepayment to an IR provider of $400,000.

  A decreased in account payable and accrued expenses of $79,982, primarily attributable to the payoff the accrued expenses related to the IPO.
  A decrease of deferred revenue of $295,176, primarily due to the completion of software development project.
  Offset by share-based compensation of $422,164.

 

Net cash used in operating activities was $850,812 for the three months ended March 31, 2021, primarily consisting of the following:

 

  Net loss of $188,237 for the three months ended March 31, 2021.
  An increase in accounts receivable of $458,314. The increase was primarily due to our increased sales in the three months ended March 31, 2021. The collected accounts receivable is available cash, which can be used as working capital for our business operation, if necessary.
  An increase in prepaid expense of $186,462, primarily due to the increase in the prepayments to software venders.
  A decrease of deferred revenue of $233,170, primarily due to the completion of software development project.
  A decrease of income tax payable of 159,991, primarily due to the decreased taxable income.
  Offset by an increase in accounts payable and accrued expenses of $319,323, primarily due to the increase in the accrued expense related to the IPO.

 

27

 

 

Investing Activities

 

Net cash used in investing activities amounted to $35,281 for the three months ended March 31, 2022, and primarily included the purchase of fixed assets of $18,903, and the loans provided to related parties of $25,480.

 

Net cash used in investing activities amounted to $64,510 for the three months ended March 31, 2021, and primarily included the purchase of fixed assets of $4,239, and the loans provided to related parties of $60,271.

 

Financing Activities

 

Net cash provided by financing activities amounted to $13,284,474 for the three months ended March 31, 2022, primarily consisting of total proceeds of $13,823,126 from the initial public offering and issuance of common shares prior to the initial public offering, and offset by payment for mandatorily redeemable financial interest of $430,489.

 

Net cash used in financing activities amounted to $346,391 for the three months ended March 31, 2021, primarily consisting of repayment of long-term debts of $328,799 and payments for finance leases of $16,172.

 

Contractual Obligations

 

Lease commitment

 

The Company’s subsidiary, HeartCore Co., Ltd. entered into two leases for its office space and parking lot, which were classified as operating leases. HeartCore Co., Ltd. also entered into two leases for office equipment and a lease for a vehicle, and these leases were classified as finance leases.

 

As of March 31, 2022, future minimum lease payments under the non-cancellable lease agreements are as follows:

 

Year ending December 31,  Finance lease   Operating lease 
Remaining of 2022  $22,755   $255,580 
2023   20,947    340,773 
2024   308    340,773 
2025   -    340,773 
2026   -    340,773 
Thereafter   -    1,743,870 
Total lease payments   44,010    3,362,542 
Less: imputed interest   (313)   (217,181)
Total lease liabilities   43,697    3,145,361 
Less: current portion   29,272    313,737 
Non-current lease liabilities  $14,425   $2,831,624 

 

Long Term Debt

 

The Company’s long-term debts included bond payable and loans borrowed from banks and other financial institutions.

 

28

 

 

As of March 31, 2022, future minimum loan payments are as follows:

 

Year ending December 31,  Loan 
   Payment 
Remaining of 2022  $569,006 
2023   767,586 
2024   475,901 
2025   273,036 
2026   248,436 
Thereafter   203,859 
Total  $2,537,824 

 

Off-Balance Sheet Arrangements

 

We did not have any off-balance sheet arrangements as of March 31, 2022.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based upon our unaudited consolidated financial statements. These financial statements are prepared in accordance with the generally accepted accounting principles in the United States (“U.S. GAAP”), which requires us to make estimates and assumptions that affect the reported amounts of our assets and liabilities and revenue and expenses, to disclose contingent assets and liabilities on the date of the consolidated financial statements, and to disclose the reported amounts of revenue and expenses incurred during the financial reporting period. We continue to evaluate the estimates and assumptions that we believe to be reasonable under the circumstances. We rely on these evaluations as the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Since the use of estimates is an integral component of the financial reporting process, actual results could differ from those estimates. Some of our accounting policies require higher degrees of judgment than others in their application. We believe critical accounting policies as disclosed herein reflect the more significant judgments and estimates used in preparation of our unaudited consolidated financial statements.

 

Revenue Recognition

 

The Company recognizes revenue under ASC Topic 606, “Revenue from Contracts with customers”.

 

To determine revenue recognition for contracts with customers, the Company performs the following five steps : (i) identify the contract(s) with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation. Revenue amount represents the invoiced value, net of a value-added tax (“Consumption Tax”) and applicable local government levies. The Consumption Tax on sales is calculated at 10% of gross sales.

 

The Company currently generates its revenue from the following main sources:

 

Revenue from On-Premise Software

 

Licenses for on-premise software provide the customer with a right to use the software as it exists when made available to the customer. The Company provides on-premise software in the form of both perpetual licenses and term-based licenses which grant the customers with the right for a specified term. Revenue from on-premise licenses is recognized upfront at the point in time when the software is made available to the customer. Licenses for on-premise software are typically sold to the customer with maintenance and support services in a bundle. Revenues under the bundled arrangements are allocated based on the relative standalone selling prices (“SSP”) of on-premise software and maintenance and support service. The SSP for maintenance and support services is estimated based upon observable transactions when those services are sold on a standalone basis. The SSP of on-premise software is typically estimated using the residual approach as the Company is unable to establish the SSP for on-premise licenses based on observable prices given the same products are sold for a broad range of amounts (that is, the selling price is highly variable) and a representative SSP is not discernible from past transactions or other observable evidence.

 

Revenue from Maintenance and Support service

 

Maintenance and support services provided with software licenses consist of trouble shooting, technical support and the right to receive unspecified software updates when and if available during the subscription. Revenues from maintenance and support services are recognized over time as such services are performed. Revenues for consumption-based services are generally recognized as the services are performed and accepted by the customers.

 

Revenue from Software as a Service (“SaaS”)

 

The Company’s software is available for use as hosted application arrangements under subscription fee agreements without licensing the rights of the software to the customers. Subscription fees from these applications are recognized over time on a ratable basis over the customer agreement term beginning on the date the Company’s solution is made available to the customer. The subscription contracts are generally one year or less in length.

 

Revenue from Software Development and other Miscellaneous Services

 

The Company provides customers with software development and support service pursuant to their specific requirements, which primarily compose of consulting, integration, training, custom application, and workflow development. The Company also provides other miscellaneous services, such as 3D Space photography. The Company generally recognized revenue at a point in time when control is transferred to the customers and the Company is entitled to the payment, which is when the promised services are delivered and accepted by the customers.

 

The timing of revenue recognition may differ from the timing of invoicing to the customers. The Company records a contract asset, which is included in accounts receivable on the consolidated balance sheets, when revenue is recognized prior to invoicing. The Company records deferred revenues on the consolidated balance sheets when revenues are recognized subsequent to cash collection for an invoice. Deferred revenues are reported net of related uncollected deferred revenues in the consolidated balance sheets. The amount of revenues recognized during the three months ended March 31, 2022 and 2021 that were included in the opening deferred revenues balance was approximately $0.8 million and $0.9 million, respectively.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

The Company’s Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2022. Based upon such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2022, the Company’s disclosure controls and procedures were not effective, for the same reason as previously disclosed under Item 9A. “Controls and Procedures” in our Annual Report on Form 10-K for our fiscal year ended December 31, 2021.

 

Changes in Internal Controls Over Financial Reporting

 

There were no changes in the Company’s internal controls over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or 15d-15 of the Exchange Act that occurred during the quarter ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we are involved in various claims and legal actions arising in the ordinary course of business. To the knowledge of our management, there are no legal proceedings currently pending against us which we believe would have a material effect on our business, financial position or results of operations and, to the best of our knowledge, there are no such legal proceedings contemplated or threatened.

 

29

 

 

ITEM 1A. RISK FACTORS

 

As a smaller reporting company, the Company is not required to disclose material changes to the risk factors that were contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as updated from time to time.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

There have been no defaults in any material payments during the covered period.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

(a) None.

 

(b) There have been no material changes to the procedures by which security holders may recommend nominees to the Company’s Board of Directors since the Company last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K.

 

ITEM 6. EXHIBITS

 

Exhibit
Number
  Description of Document
     
10.1†   Employment Agreement, dated February 9, 2022, between the Company and Sumitaka Yamamoto (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed with the SEC on February 14, 2022).
     
10.2†   Employment Agreement, dated February 9, 2022, between the Company and Kimio Hosaka (incorporated by reference to Exhibit 10.2 to the registrant’s Current Report on Form 8-K filed with the SEC on February 14, 2022).
     
10.3†   Employment Agreement, dated February 9, 2022, between the Company and Keisuke Kuno (incorporated by reference to Exhibit 10.3 to the registrant’s Current Report on Form 8-K filed with the SEC on February 14, 2022).
     
10.4†   Employment Agreement, dated February 9, 2022, between the Company and Qizhi Gao (incorporated by reference to Exhibit 10.4 to the registrant’s Current Report on Form 8-K filed with the SEC on February 14, 2022).
     
10.5†   Employment Agreement, dated February 9, 2022, between the Company and Hidekazu Miyata (incorporated by reference to Exhibit 10.5 to the registrant’s Current Report on Form 8-K filed with the SEC on February 14, 2022).

 

30

 

 

Exhibit Number   Description of Document
     
10.6†   Form of Independent Director Agreement between HeartCore Enterprises, Inc. and each independent director (incorporated by reference to Exhibit 10.10 to the registrant’s Registration Statement on Form S-1 (File No. 333-261984) filed with the SEC on January 3, 2022).
     
10.7†   Form of Indemnification Agreement between HeartCore Enterprises, Inc. and each independent director (incorporated by reference to Exhibit 10.11 to the registrant’s Registration Statement on Form S-1 (File No. 333-261984) filed with the SEC on January 3, 2022).
     
10.8†   Consulting and Services Agreement, dated as of March 31, 2022, by and between the registrant and Moveaction Co., Ltd. (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed with the SEC on April 6, 2022).
     
10.9†   Common Stock Purchase Warrant issued by Moveaction Co., Ltd. to the registrant (incorporated by reference to Exhibit 10.2 to the registrant’s Current Report on Form 8-K filed with the SEC on April 6, 2022).
     
31.1*   Rule 13a-14(a) Certification of Principal Executive Officer.
     
31.2*   Rule 13a-14(a) Certification of Principal Financial Officer.
     
32.1**   Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of Principal Executive Officer and Principal Financial Officer.
     
101.INS*   Inline XBRL Instance Document
     
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase
     
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase
     
101.LAB*   Inline XBRL Taxonomy Extension Labels Linkbase
     
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase
     
104*   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.
** Furnished herewith.
Management contracts and compensation plans and arrangements.

 

31

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

 

  HEARTCORE ENTERPRISES, INC.
     
Dated: May 16, 2022 By: /s/ Sumitaka Yamamoto
    Sumitaka Yamamoto
    Chief Executive Officer and President (principal executive officer)
     
Dated: May 16, 2022 By: /s/ Qizhi Gao
    Qizhi Gao
    Chief Financial Officer (principal financial officer and principal accounting officer)

 

32
HeartCore Enterprises (NASDAQ:HTCR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more HeartCore Enterprises Charts.
HeartCore Enterprises (NASDAQ:HTCR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more HeartCore Enterprises Charts.